CALIBRATION clinical trial: Member of Trial Steering Committee

Activity: Other activity typesOther


“CALIBRATION”: An exploratory study in patients with advanced oesophageal malignancies receiving MEDI4736 (Durvalumab), investigating whether early changes in circulating tumour DNA can predict tumour response. The role of the Trial Steering Committee (TSC) is to provide overall supervision for the CALIBRATION trial on behalf of the Trial Sponsor and the Trial Funder and to ensure that, the trial is conducted according to the guidelines for Good Clinical Practice (GCP), Research Governance Framework for Health and Social Care and all relevant regulations and local policies.
Period15 May 2019 → …
Degree of RecognitionInternational